Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia after influenza.
Tong
Steven Y C
SY
Anstey
Nicholas M
NM
Lum
Gary D
GD
Lilliebridge
Rachael A
RA
Stephens
Dianne P
DP
Currie
Bart J
BJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000235:genetics; D017714:Community-Acquired Infections / Q000150:complications / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005098:Exotoxins / Q000235:genetics; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007251:Influenza, Human / Q000382:microbiology*; D007956:Leukocidins / Q000235:genetics; D016106:Methicillin Resistance; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D020641:Polymorphism, Single Nucleotide; D012131:Respiratory Insufficiency / Q000209:etiology; D013203:Staphylococcal Infections / Q000150:complications* / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000235:genetics / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin